HFQRX
Price
$8.10
Change
-$0.05 (-0.61%)
Updated
Jul 23 closing price
Net Assets
7.55B
PJRAX
Price
$10.56
Change
-$0.08 (-0.75%)
Updated
Jul 24 closing price
Net Assets
435.06M
Interact to see
Advertisement

HFQRX vs PJRAX

HFQRX vs PJRAX Comparison Chart in %
View a ticker or compare two or three
VS
HFQRX vs. PJRAX commentary
Jul 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFQRX is a Buy and PJRAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HFQRX has more cash in the bank: 7.55B vs. PJRAX (435M). HFQRX pays higher dividends than PJRAX: HFQRX (6.36) vs PJRAX (1.46). HFQRX was incepted earlier than PJRAX: HFQRX (11 years) vs PJRAX (26 years). PJRAX (1.53) is less costly to investors than HFQRX (0.69). HFQRX is a more actively managed with annual turnover of: 175.00 vs. PJRAX (129.00). PJRAX has a lower initial minimum investment than HFQRX: PJRAX (1000) vs HFQRX (1000000). HFQRX annual gain was more profitable for investors over the last year : 22.61 vs. PJRAX (16.25). HFQRX return over 5 years is better than : 73.83 vs. PJRAX (38.80).
HFQRXPJRAXHFQRX / PJRAX
Total Expense Ratio0.691.3950%
Annual Report Gross Expense Ratio0.691.5345%
Fund Existence11 years26 years-
Gain YTD14.83311.392130%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets7.55B435M1,736%
Annual Yield % from dividends6.361.46436%
Returns for 1 year22.6116.25139%
Returns for 3 years63.7867.0095%
Returns for 5 years73.8338.80190%
Returns for 10 years130.07102.46127%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWEIX9.370.09
+0.97%
American Century Equity Income Inv
DDVAX12.740.12
+0.95%
Nomura Value A
IJEMX17.10N/A
N/A
VY® JPMorgan Emerging Markets Equity I
LHCAX23.37-0.04
-0.17%
Lord Abbett Health Care A
SSTFX9.67-0.12
-1.23%
Virtus KAR Capital Growth C